Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Jiangsu Hansoh Pharmaceutical Co., Ltd..
Real, source-linked trial activity for Jiangsu Hansoh Pharmaceutical Co., Ltd.: 5 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 29, 2026. Source-linked, daily-refreshed.
PHASE1 2PHASE3 2PHASE2 1
Newest Jiangsu Hansoh Pharmaceutical Co., Ltd. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacoki | Ph 1 | RECRUITING | ↗ |
| 42d ago | A Phase I Clinical Trial to Evaluate Pharmacokinetics of HS-10504 | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 46d ago | A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Par | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 48d ago | A Study to Evaluate the Long-term Safety of HS-10380 in Patients With | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 50d ago | Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Jiangsu Hansoh Pharmaceutical Co., Ltd. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.